Auris Medical Stock Price (NASDAQ:EARS)

Add to My Stocks
$0.29 $0 (0%) EARS stock closing price Sep 18, 2018 (Closing)
Prev Close* : $0.29
Market Cap:
$1.79M
Day Low: $0.28
52 Week Low: $0.23
Open: $0.29
Volume: -
Day High: $0.33
52 Week High: $9.50
Dividend:
0.00

Latest Stock Market News

Latest Articles

Auris Medical News - From Partners

Auris Medical Provides Board of Directors Update   by Globe Newswire on Sep 26, 2017

EARS Stockcharts

View EARS PE ratio, PS ratio stocks charts and compare with peers.
EARS Chart
Note: Compare Auris Medical stock price history with the index and industry peers.

Auris Medical Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Auris Medical Returns

ROE
(return on equity)

Auris Medical Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

EARS Industry Peers

Company Price Change (%)
Generex Biotech (GNBT)1.970.06 (3.14%)
Skinvisible (SKVI)0.020 (0%)
Aralez Pharma (ARLZQ)0.020 (0%)
Novadel Pharma (NVDL)0.010 (0%)
Auspex Pharma (ASPX)100.960 (0%)
Novartis (NVS)85.030.1 (0.12%)
Novartis (NVS)85.030.1 (0.12%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

Auris Medical Holding AG Stock News - Partner Headlines

Auris Medical Financial Statements

income statement2017201620152014
Net Sales or Revenues----
Net Income-24.8M-31.13M-28.55M-19.9M
Total Operating Expense24.75M30.67M29.67M24.28M
View Auris Medical income statement
balance sheet2017201620152014
Total Assets18.11M36.2M52.88M65.1M
Total Liabilities20.31M21.84M8.08M6.79M
Shareholders Equity-2.19M14.35M44.8M58.3M
View Auris Medical balance sheet
cash flow statement2017201620152014
Net Increase (Decrease) in Assets Liabilities-0.47M-1.6M2.85M
Net Cash from (used by) Operating Activities-24.67M-29.9M-27.61M-21.13M
Increase (Decrease) in Prop Plant And Equipment-0.01M-0.24M-0.07M-1.29M
View Auris Medical cash flow statement

Auris Medical Stock Message Board

As of last trading day, Auris Medical stock price was $0.29. Looking at Auris Medical market capitalization, which currently stands at $1.79M, we can say that EARS stock is a Nano Cap stock. Auris Medical valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

For recognizing and analyzing the real performance of Auris Medical stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in Auris Medical stock quote data shows the number of shares traded. For Ex: 1,097,534 Auris Medical shares were traded as of last trading day, as seen from Auris Medical stock chart. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Auris Medical stock dividend was 0.00 during the last quarter. One can observe stock price trends and check for volatility by checking Auris Medical stock price history.